Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Christophe Lega

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Haematologica|December 5, 2015
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patientsGaëlle Fossard, Emilie Blond, Marie Balsat, et al.
Pediatric Rheumatology Online Journal|October 4, 2014
Mutations in CECR1 associated with a neutrophil signature in peripheral bloodAlexandre Belot, Evangeline Wassmer, Marinka Twilt, et al.
Autoimmunity Reviews|May 7, 2018
Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registrySabine Jardel, Xavier Puéchal, Alain Le Quellec, et al.
Rheumatology (Oxford, England)|December 17, 2021
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patientsMickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, et al.
Joint Bone Spine|September 12, 2018
Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte databaseNatalia Cabrera, Jean-Christophe Lega, Behrouz Kassai, et al.
Immunologic Research|January 9, 2016
Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric studyCécile Picard, Thierry Vincent, Jean-Christophe Lega, et al.
American Journal of Hematology|October 18, 2021
Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatmentArthur Mageau, Louis Terriou, Mikael Ebbo, et al.
Arthritis Research & Therapy|February 20, 2020
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosisEmmanuel Ledoult, David Launay, Hélène Béhal, et al.
British Journal of Haematology|January 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registryGuillaume Moulis, Manuela Rueter, Aymeric Duvivier, et al.
La Revue De Medecine Interne|November 5, 2024
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)Hubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Haematologica|December 5, 2015
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patientsGaëlle Fossard, Emilie Blond, Marie Balsat, et al.
Pediatric Rheumatology Online Journal|October 4, 2014
Mutations in CECR1 associated with a neutrophil signature in peripheral bloodAlexandre Belot, Evangeline Wassmer, Marinka Twilt, et al.
Autoimmunity Reviews|May 7, 2018
Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registrySabine Jardel, Xavier Puéchal, Alain Le Quellec, et al.
Rheumatology (Oxford, England)|December 17, 2021
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patientsMickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, et al.
Joint Bone Spine|September 12, 2018
Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte databaseNatalia Cabrera, Jean-Christophe Lega, Behrouz Kassai, et al.
Immunologic Research|January 9, 2016
Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric studyCécile Picard, Thierry Vincent, Jean-Christophe Lega, et al.
American Journal of Hematology|October 18, 2021
Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatmentArthur Mageau, Louis Terriou, Mikael Ebbo, et al.
Arthritis Research & Therapy|February 20, 2020
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosisEmmanuel Ledoult, David Launay, Hélène Béhal, et al.
British Journal of Haematology|January 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registryGuillaume Moulis, Manuela Rueter, Aymeric Duvivier, et al.
La Revue De Medecine Interne|November 5, 2024
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)Hubert de Boysson, Valérie Devauchelle-Pensec, Christian Agard, et al.
Pageof 12